Grown Rogue International (GRUSF) Shares Outstanding (Weighted Average) (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Shares Outstanding (Weighted Average) of $249.9 million in Q1 2026, up 6147.86% quarter-over-quarter from $4.0 million in Q4 2025, and down 99.4% on a YoY basis from $41.4 billion in Q1 2025.
Grown Rogue International (GRUSF) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Grown Rogue International's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $249.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 99.4% year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (down 99.4% YoY), while the FY2025 annual figure was $4.0 million, down 99.99% from the prior year.
- Shares Outstanding (Weighted Average) was $249.9 million for Q1 2026 at Grown Rogue International, up from $4.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $41.4 billion in Q1 2025 to a low of $4.0 million in Q4 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $7.8 billion across 5 years, with a median of $177.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) surged 22478.2% in 2025, then tumbled 99.4% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $128.5 million in 2022, then plunged by 81.83% to $23.3 million in 2023, then dropped by 2.54% to $22.7 million in 2024, then slumped by 82.41% to $4.0 million in 2025, then soared by 6147.86% to $249.9 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $249.9 million (Q1 2026), $4.0 million (Q4 2025), and $249.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 249.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.91 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 249.56 Mn |
| Jun 30, 2025 | 246.99 Mn |
| Mar 31, 2025 | 41.36 Bn |
| Dec 31, 2024 | 22.74 Mn |
| Sep 30, 2024 | 38.61 Bn |
| Jun 30, 2024 | 27.14 Bn |
| Mar 31, 2024 | 183.18 Mn |
| Dec 31, 2023 | 23.34 Mn |
| Oct 31, 2023 | 134.23 Mn |
| Jul 31, 2023 | 170.83 Mn |
| Oct 31, 2022 | 128.47 Mn |
| Jan 31, 2022 | 164.98 Mn |
| Oct 31, 2021 | 124.83 Mn |
| Jul 31, 2021 | 163.25 Mn |
| Apr 30, 2021 | 19.20 Bn |
| Jan 31, 2021 | 14.63 Bn |
| Oct 31, 2020 | 14.42 Bn |
| Jul 31, 2020 | 14.77 Bn |